Skip to main content

Advertisement

Table 1 Descriptive statistics of clinical trial, placebo arm MS patients derived from the open data set of the SLCMSR and included in "Individual Risk Profile" OLAP-tool, version 2.0.0, divided by the four different courses CIS clinically isolated syndrome, RR relapsing remitting, SP secondary progressive and PP primary progressive.

From: Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis

  Disease subtype
Database patient characteristics CIS RR SP PP
No. of patients 124 460 455 20
Sex ratio (m/f) 0.38 0.41 0.69 0.82
Age at onset (Median and 5%- and 95%- percentile) 30 [19;40] 29 [17;41] 29 [18;45] 37 [19;57]
Baseline EDSS (Median and 5%- and 95%- percentile) 1.5 [0.0;5.0] 2.5 [1.0;5.5] 5.5 [3.0;6.5] 3.5 [1.5;6.0]
Duration (months) (Median and 5%- and 95%- percentile) 2 [0;104] 66 [7;225] 148 [40;341] 50 [11;190]
Relapses last 12 months: no relapse 5 47 256 6
Relapses last 12 months: 1 relapse 115 131 97 4
Relapses last 12 months: 2 or more relapses 0 132 36 1
Relapses last 12 months: unknown 4 150 66 9
  1. The values in brackets are the 5%- and 95%- percentile.